Literature DB >> 22903654

Cardiac imaging techniques for physicians: late enhancement.

Peter Kellman1, Andrew E Arai.   

Abstract

Late enhancement imaging is used to diagnose and characterize a wide range of ischemic and nonischemic cardiomyopathies, and its use has become ubiquitous in the cardiac MR exam. As the use of late enhancement imaging has matured and the span of applications has widened, the demands on image quality have grown. The characterization of subendocardial MI now includes the accurate quantification of scar size, shape, and characterization of borders which have been shown to have prognostic significance. More diverse patterns of late enhancement including patchy, mid-wall, subepicardial, or diffuse enhancement are of interest in diagnosing nonischemic cardiomyopathies. As clinicians are examining late enhancement images for more subtle indication of fibrosis, the demand for lower artifacts has increased. A range of new techniques have emerged to improve the speed and quality of late enhancement imaging including: methods for acquisition during free breathing, and fat water separated imaging for characterizing fibrofatty infiltration and reduction of artifacts related to the presence of fat. Methods for quantification of T1 and extracellular volume fraction are emerging to tackle the issue of discriminating globally diffuse fibrosis from normal healthy tissue which is challenging using conventional late enhancement methods. The aim of this review will be to describe the current state of the art and to provide a guide to various clinical protocols that are commonly used. Published 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22903654      PMCID: PMC3428749          DOI: 10.1002/jmri.23605

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  66 in total

1.  Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality.

Authors:  Andrew T Yan; Adolphe J Shayne; Kenneth A Brown; Sandeep N Gupta; Carmen W Chan; Tuan M Luu; Marcelo F Di Carli; H Glenn Reynolds; William G Stevenson; Raymond Y Kwong
Journal:  Circulation       Date:  2006-06-26       Impact factor: 29.690

2.  Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium: are they different diseases?

Authors:  A P Burke; A Farb; G Tashko; R Virmani
Journal:  Circulation       Date:  1998-04-28       Impact factor: 29.690

3.  Motion correction for myocardial T1 mapping using image registration with synthetic image estimation.

Authors:  Hui Xue; Saurabh Shah; Andreas Greiser; Christoph Guetter; Arne Littmann; Marie-Pierre Jolly; Andrew E Arai; Sven Zuehlsdorff; Jens Guehring; Peter Kellman
Journal:  Magn Reson Med       Date:  2011-08-29       Impact factor: 4.668

4.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

5.  Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement.

Authors:  Peter Kellman; Andrew E Arai; Elliot R McVeigh; Anthony H Aletras
Journal:  Magn Reson Med       Date:  2002-02       Impact factor: 4.668

6.  Phase-sensitive inversion recovery (PSIR) single-shot TrueFISP for assessment of myocardial infarction at 3 tesla.

Authors:  Armin Huber; Kerstin Bauner; Bernd J Wintersperger; Scott B Reeder; Frank Stadie; Edgar Mueller; Michaela Schmidt; Eva Winnik; Maximilian F Reiser; Stefan O Schoenberg
Journal:  Invest Radiol       Date:  2006-02       Impact factor: 6.016

7.  Quantitative myocardial infarction on delayed enhancement MRI. Part I: Animal validation of an automated feature analysis and combined thresholding infarct sizing algorithm.

Authors:  Li-Yueh Hsu; Alex Natanzon; Peter Kellman; Glenn A Hirsch; Anthony H Aletras; Andrew E Arai
Journal:  J Magn Reson Imaging       Date:  2006-03       Impact factor: 4.813

8.  Cardiovascular magnetic resonance in cardiac amyloidosis.

Authors:  Alicia Maria Maceira; Jayshree Joshi; Sanjay Kumar Prasad; James Charles Moon; Enrica Perugini; Idris Harding; Mary Noelle Sheppard; Philip Alexander Poole-Wilson; Philip Nigel Hawkins; Dudley John Pennell
Journal:  Circulation       Date:  2005-01-03       Impact factor: 29.690

9.  T1 mapping of the gadolinium-enhanced myocardium: adjustment for factors affecting interpatient comparison.

Authors:  Neville Gai; Evrim B Turkbey; Saman Nazarian; Rob J van der Geest; Chia-Ying Liu; João A C Lima; David A Bluemke
Journal:  Magn Reson Med       Date:  2010-12-16       Impact factor: 4.668

10.  Inversion-recovery-prepared SSFP for cardiac-phase-resolved delayed-enhancement MRI.

Authors:  J S Detsky; J A Stainsby; R Vijayaraghavan; J J Graham; A J Dick; G A Wright
Journal:  Magn Reson Med       Date:  2007-08       Impact factor: 4.668

View more
  61 in total

Review 1.  Utility of late gadolinium enhancement in pediatric cardiac MRI.

Authors:  Maryam Etesami; Robert C Gilkeson; Prabhakar Rajiah
Journal:  Pediatr Radiol       Date:  2015-12-30

2.  Multicenter review: role of cardiovascular magnetic resonance in diagnostic evaluation, pre-procedural planning and follow-up for patients with congenital heart disease.

Authors:  Nicolò Schicchi; Aurelio Secinaro; Giuseppe Muscogiuri; Paolo Ciliberti; Benedetta Leonardi; Teresa Santangelo; Carmela Napolitano; Giacomo Agliata; Maria Chiara Basile; Francesca Guidi; Paolo Tomà; Andrea Giovagnoni
Journal:  Radiol Med       Date:  2015-12-11       Impact factor: 3.469

Review 3.  Review of key concepts in magnetic resonance physics.

Authors:  Michael M Moore; Taylor Chung
Journal:  Pediatr Radiol       Date:  2017-04-13

4.  Role of 3-Dimensional Architecture of Scar and Surviving Tissue in Ventricular Tachycardia: Insights From High-Resolution Ex Vivo Porcine Models.

Authors:  Farhad Pashakhanloo; Daniel A Herzka; Henry Halperin; Elliot R McVeigh; Natalia A Trayanova
Journal:  Circ Arrhythm Electrophysiol       Date:  2018-06

5.  Electrical and Structural Substrate of Arrhythmogenic Right Ventricular Cardiomyopathy Determined Using Noninvasive Electrocardiographic Imaging and Late Gadolinium Magnetic Resonance Imaging.

Authors:  Christopher M Andrews; Neil T Srinivasan; Stefania Rosmini; Heerajnarain Bulluck; Michele Orini; Sharon Jenkins; Antonis Pantazis; William J McKenna; James C Moon; Pier D Lambiase; Yoram Rudy
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-07

Review 6.  Multimodality Imaging of Myocardial Viability.

Authors:  Kinjan Parikh; Alana Choy-Shan; Munir Ghesani; Robert Donnino
Journal:  Curr Cardiol Rep       Date:  2021-01-04       Impact factor: 2.931

Review 7.  A new look at the heart-novel imaging techniques.

Authors:  C M Johnston; A J Krafft; M F Russe; E A Rog-Zielinska
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2017-12-14

Review 8.  Cardiovascular magnetic resonance imaging for structural heart disease.

Authors:  Yiling Situ; Samuel C M Birch; Camila Moreyra; Cameron J Holloway
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

9.  Free-breathing, motion-corrected late gadolinium enhancement is robust and extends risk stratification to vulnerable patients.

Authors:  Kayla M Piehler; Timothy C Wong; Kathy S Puntil; Karolina M Zareba; Kathie Lin; David M Harris; Christopher R Deible; Joan M Lacomis; Ferenc Czeyda-Pommersheim; Stephen C Cook; Peter Kellman; Erik B Schelbert
Journal:  Circ Cardiovasc Imaging       Date:  2013-04-18       Impact factor: 7.792

10.  Free breathing three-dimensional late gadolinium enhancement cardiovascular magnetic resonance using outer volume suppressed projection navigators.

Authors:  Rajiv G Menon; G Wilson Miller; Jean Jeudy; Sanjay Rajagopalan; Taehoon Shin
Journal:  Magn Reson Med       Date:  2016-04-28       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.